The EBMT is a non-profit organization established in 1974. For more than 47 years, has developed into the leading scientific society in Europe in the cutting-edge field of stem cell transplantation and cellular therapy.
The EBMT has offices based in Barcelona, Leiden and Paris, and currently has over 140 employees. If you are looking to join non-profit organisation where you can make a difference, apply to one of the open staff or society career opportunities posted below:
EBMT Staff Vacancies
Are you looking for a job where you can make a difference and work in a non-profit?
Would you like to be a part of an international organisation on the cutting edge of science?
EBMT Society Vacancies
Our society aims to be the connection between patients, researchers and other stakeholders to anticipate the future of cellular and stem cell-based therapies. If you're looking for a position within an EBMT Working Party, EBMT Committee or the EBMT Nurses Group, see below:
External Vacancies
Head of the Hematology-Oncology service - Hôpital Saint-Louis, Paris (Assistance Publique- Hôpitaux de Paris, AP-HP)
Institutional Context: Renewal of a Head of service
The University Medical Department (DMU) of Hematology-Immunology at Saint-Louis, Robert-Debré (Paris), and Avicenne (Bobigny) Hospitals – AP-HP Nord – is recruiting a Medical Head for the adult hematology-oncology service at Saint-Louis Hospital, a leading center for the management of lymphoid malignancies (lymphomas and CLL).
Anticipated start date: September 2026 – discussions with the governing body are possible depending on the selected candidate.
The new Head of service will be responsible for modernizing the organization of care, consolidating the lymphoma/CLL pathway, and strengthening integration with clinical and translational research (Saint-Louis Research Institute, biology and clinical trial platforms (Saint-Louis Clinical Research Unit)).
The medical unit
Completely renovated and expanded in 2025, it offers:
• 22 inpatient beds in single rooms, dedicated to lymphoid malignancies: chemotherapy, immunotherapy, autologous stem cell transplantation, and CAR-T cell therapy (80 in 2025).
• 7 day hospital places (15-20 visits/day) within the hematology-immunology polyclinic, which also hosts the department's outpatient consultations (4,000-5,000/year).
• Activity focused on chemotherapy, immunotherapy, and innovative therapies.
The medical team consists of 1 Professor of Medicine, 2 Hospital Practitioners, 2 Associate Physicians, and 2 Assistant professors. Additional physician positions are planned with the service expansion; these will be filled by the future head of service. The service also has 2 residency positions in hematology, supplemented very regularly by a resident on inter-hospital rotations.
Main mission:
The Head of the Hematology-Oncology service will lead the clinical, scientific, and educational activities of the service, with specific expertise in lymphoma and chronic lymphocytic leukemia (CLL), as well as mastery of therapeutic innovations such as cellular immunotherapies, CAR T-cell therapies, bispecific antibodies, and intensive treatments (autologous stem cell transplantation). He/she will be responsible for ensuring the quality of care, directing clinical trials, and fostering research development in these areas.
A leading research environment
The Hematology-Immunology Medical-University Department (DMU) of Saint-Louis, Robert-Debré (Paris), and Avicenne (Bobigny) Hospitals – AP-HP North is one of the largest hematology centers in Europe, with high-level clinical activity and a rich academic environment. It benefits from an exceptional scientific structure, including:
• a CLIP²-accredited Clinical Investigation Center (CIC) (Center for Early Phase Trials in Hematological Cancers),
• direct access to early-phase trials, innovative therapies, and translational research platforms,
• close ties with the IRSL (Saint Louis Research Institute) and internationally renowned biology and research teams,
• active participation in national and international clinical trial networks (LYSA Group, etc.)
• This environment fosters academic development, participation in Phase I/II/III studies, and involvement in innovative research programs.
Responsibilities:
• Supervise and coordinate the medical and paramedical teams of the service in conjunction with the paramedical supervisor.
• Lead therapeutic innovation projects and clinical trials in the field of hematology-oncology, particularly in lymphomas, chronic lymphocytic leukemia (CLL), and cell therapies.
• Implement cutting-edge therapeutic protocols, especially in immunotherapies.
• Contribute to the training and education of residents, junior physicians, and healthcare teams, within a framework of continuing medical education.
• Conduct basic and clinical research activities in collaboration with the hospital's research teams and academic partners.
Skills and Qualifications:
• Specialist physician in hematology and/or clinical immunology.
• Recognized expertise in lymphomas and CLL, with significant experience in cell-based immunotherapies and clinical trials.
• Additional training or proven experience in therapeutic innovation (CAR T-cells, bispecific antibodies, autologous stem cell transplantation).
• Team management and research project management skills.
Strong teaching and mentoring abilities.
Recognized expertise in the field of lymphomas is essential.
Desired Qualities:
Leadership, scientific rigor, innovative spirit, ability to work in an interdisciplinary team and promote clinical excellence and research.
Location: Hôpital Saint-Louis, Paris
Applications should be sent to:
-the APHP Nord Management: Mr. Du Chaffaut, director (guillaume.duchaffaut@aphp.fr) ; Professor Anne Couvelard, head of the medical committee (anne.couvelard@aphp.fr ); Professor Sabine Sarnaki, Dean of University Paris Cité faculty of medicine (sabine.sarnacki@aphp.fr )
-Professor Pierre Fenaux, head of the University Medical Department (DMU) of Hematology-Immunology at Saint-Louis, Robert-Debré (Paris), and Avicenne (Bobigny) Hospitals – AP-HP Nord (pierre.fenaux@aphp.fr)
Junior Hematologist - Hôpital Saint-Louis, Paris (Assistance Publique- Hôpitaux de Paris, AP-HP)
The Hematology-Oncology service at Hôpital Saint-Louis (AP-HP, University of Paris, France), part of the department of hematology and immunology, is seeking a junior hematologist to join as a Contractual Hospital Practitioner (PHC), with the possibility of advancement to a permanent Hospital Practitioner (PH) position within two years.
The department specializes in the diagnosis and treatment of lymphomas and chronic lymphocytic leukemia (CLL). Its activities include inpatient care, day hospital services, and outpatient clinics, with a strong commitment to clinical and translational research. Furthermore, it holds specialized accreditations including LRIPH (authorized center for clinical research in humans, ARS 2023) and JACIE accreditation, an international benchmark for transplant programs. It is also a leading center for CAR-T cell therapies and bispecific antibodies.
Since 2022, the service has participated in 73 active clinical trials, with about 70 patients treated with CAR-T every year and an increasing number with bispecific antibodies, placing it among the leading European centers in cell immunotherapy.
Desired profile: Hematology specialist (European or French recognized qualification), with an interest in clinical practice and research. A high level of French is not required (but a commitment to improvement is essential).
Position: Clinical Physician with the possibility of becoming a permanent Physician after about 18 months.
Salary: initially about 4500 € gross monthly base salary + additional allowances for on-call shifts and for morning attendance on weekends/holidays.
Vacation: 25 working days + 20 days (of “reduced working hours”) every year
Applications: Please send your updated CV and cover letter to:
Prof. Pierre Fenaux : pierre.fenaux@aphp.fr (Head of Department)
Prof. Catherine Thiéblemont: catherine.thieblemont@aphp.fr (Head of Hematology Oncology Service)